Mirae Asset Global Investments Co., Ltd. Inovio Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.79 - $1.91 $73,022 - $176,548	92,434 New	92,434 $75,000
Q2 2022 Jul 26, 2022	SELL	$1.44 - $3.98 $41,384 - $114,381	-28,739 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$2.97 - $5.2 $41,158 - $72,061	13,858 Added 93.13%	28,739 $103,000
Q4 2021 Feb 08, 2022	BUY	$4.99 - $7.46 $74,256 - $111,012	14,881 New	14,881 $75,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.